NDC 0859-2346-01 - Advantage Multi for Cats
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0859-2346
- Requested NDC
- 0859-2346-01
- Package NDCs from labels
- 0859-2346-03, 0859-2346-02, 0859-2346-01
- Manufacturer
- Bayer HealthCare LLC Animal Health Division
- Effective date
- 2020-12-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Advantage Multi for Cats - Bayer HealthCare LLC Animal Health Division | Bayer HealthCare LLC Animal Health Division | 2020-12-02 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| IMIDACLOPRID | ACTIVE INGREDIENT | 3BN7M937V8 | ADVANTAGE MULTI FOR CATS (IMIDACLOPRID AND MOXIDECTIN) SOLUTION [BAYER HEALTHCARE LLC ANIMAL HEALTH DIVISION] | 5 | |
| MOXIDECTIN | ACTIVE INGREDIENT | NGU5H31YO9 | ADVANTAGE MULTI FOR CATS (IMIDACLOPRID AND MOXIDECTIN) SOLUTION [BAYER HEALTHCARE LLC ANIMAL HEALTH DIVISION] | 5 | |
| IMIDACLOPRID | ACTIVE MOIETY | 3BN7M937V8 | ADVANTAGE MULTI FOR CATS (IMIDACLOPRID AND MOXIDECTIN) SOLUTION [BAYER HEALTHCARE LLC ANIMAL HEALTH DIVISION] | 5 | |
| MOXIDECTIN | ACTIVE MOIETY | NGU5H31YO9 | ADVANTAGE MULTI FOR CATS (IMIDACLOPRID AND MOXIDECTIN) SOLUTION [BAYER HEALTHCARE LLC ANIMAL HEALTH DIVISION] | 5 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Moxidectin | MOXIDECTIN | Medicines Development for Global Health | 6eb02ae9-9065-176f-e053-2991aa0ac891 | 2026-07-30 | Warnings, Adverse reactions | NGU5H31YO9 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.